angiotensin receptor; antivirus agent; beta adrenergic receptor blocking agent; ensitrelvir; mineralocorticoid; molnupiravir; nirmatrelvir plus ritonavir; sodium glucose cotransporter 2 inhibitor; vaccine; antiviral therapy; coronary artery disease; coronary artery recanalization; coronavirus disease 2019; evidence based practice; human; maternal hypertension; meta analysis (topic); nutrition; pandemic; percutaneous coronary intervention; practice guideline; review; scientific literature; septic shock; paxlovid